Iterum Therapeutics plc
No trades
Price target
5.500.000.00%
The 2 analysts offering 1-year price forecasts have a max estimate of — and a min estimate of —.
Analyst rating
Based on 2 analysts giving stock ratings in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
ITRM EPS for the last quarter is −0.16 USD despite the estimation of −0.09 USD. In the next quarter EPS is expected to reach −0.14 USD. Track more of Iterum Therapeutics plc financials and stay on top of what is up with the company.
In the next quarter Iterum Therapeutics plc revenue is expected to reach 505.00 K USD. Check out Iterum Therapeutics plc revenue and earnings and make informed decisions.
According to analysts, ITRM price target is 5.50 USD with a max estimate of 9.00 USD and a min estimate of 2.00 USD. Check if this forecast comes true in a year, meanwhile watch Iterum Therapeutics plc stock price chart and keep track of the current situation with ITRM news and stock market news.